91桃色

ISSN: 2332-0877

Journal of Infectious Diseases & Therapy
Open 91桃色

Our Group organises 3000+ Global Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open 91桃色 Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open 91桃色 Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)
  • Research Article   
  • J Infect Dis Ther,
  • DOI: 10.4173/2332-0877.24.S8.002

Impact of MicroRNA (miR453, miR608, miR499, miR423) on the Risk of Developing MDR-TB in an Amazonian Mixed-Race Population

Aidalucy Do Socorro Costa De Athayde1*, Diana Feio Da Veiga Borges Leal2, Lucas Favacho Pastana2, Marianne Rodrigues Fernandes2, Rita De Cassia Calderaro Coelho2, Ana Caroline Alves Da Costa2, Sidney Emanuel Batista Dos Santos2, Paulo Pimentel De Assuncao2 and Ney Pereira Carneiro Dos Santos2
1Department of Infectious and Parasitic Diseases, Universidade Federal do Pará, Belém, Brazil
2Department of Oncology,Oncology Research Center, Federal University of Pará, Belém, Brazil
*Corresponding Author : Aidalucy Do Socorro Costa De Athayde, Department of Infectious and Parasitic Diseases, Universidade Federal do Pará, Belém, Brazil, Email: aidalucyathayde@gmail.com

Received Date: Aug 28, 2024 / Published Date: Sep 28, 2024

Abstract

Tuberculosis (TB) continues to be a major global health problem, with the emergence and spread of Multidrug-Resistant Tuberculosis (MDR-TB). Genetic factors play a significant role in determining susceptibility to TB and the development of drug resistance. Brazil is in one of the most genetically diverse populations in the world due to the high mix between Amerindian, African and European populations, which makes this population unique in relation to the world for genomic studies. This study aimed to investigate the genotypic differences in MDR-TB-associated variants and their potential implications as genetic markers for these conditions in a Brazilian Amazon population with a high degree of admixture. This case-control study was conducted on 190 subjects, including 165 TB patients and 25 MDR-TB patients. The case group was composed of individuals diagnosed with MDR-TB, while the control group was composed of TB patients at the João Barros Barreto Hospital, in Belém (Pará-Basil). Statistical tests revealed significant differences in African ancestry between MDR-TB groups. The results regarding the investigated SNVs were significant for the risk of developing MDR-TB for mRNA: miR453 rs56103835, miR608 rs4919510, miR499 rs3746444 and miR423 rs6505162. These Single-Nucleotide Polymorphism (SNVs) should be better investigated in subsequent studies with larger populations, as the population found in this study was small, which may have limited the causal relationships; in this way, new research can map populations susceptible to severe forms of tuberculosis. With the aim of applying new, more effective and individualized diagnostic means, based on genomics, contributing to reducing the socioeconomic impact in countries affected by forms of multidrug-resistant tuberculosis, equipping governments and public policies to identify susceptible people, monitor the treatment and avoid wasting time and resources.

Keywords: Genetic variation; Mix population; Multidrug-resistant tuberculosis

Citation: Athayde AC, Leal DF, Pastana LF, Fernandes MR, Coelho RD, et al. (2024) Impact of MicroRNA (miR453, miR608, miR499, miR423) on the Risk of Developing MDR-TB in an Amazonian Mixed-Race Population. J Infect Dis Ther 12:002. Doi: 10.4173/2332-0877.24.S8.002

Copyright: © 2024 Athayde AC, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

International Conferences 2025-26
 
Meet Inspiring Speakers and Experts at our 3000+ Global

Conferences by Country

Medical & Clinical Conferences

Conferences By Subject

Top